X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (29) 29
infectious diseases (29) 29
humans (28) 28
female (21) 21
immunology (21) 21
hiv infections - virology (18) 18
human immunodeficiency virus--hiv (16) 16
antiretroviral therapy (15) 15
hiv infections - drug therapy (15) 15
male (15) 15
hiv infections - epidemiology (14) 14
uganda (14) 14
virology (14) 14
adolescent (13) 13
adult (13) 13
disease progression (13) 13
hiv-1 - genetics (13) 13
africa (12) 12
drug resistance (12) 12
genotype (12) 12
aids/hiv (11) 11
hiv (11) 11
hiv-1 - drug effects (10) 10
mutation (10) 10
young adult (10) 10
antiretroviral drugs (9) 9
antiviral agents (9) 9
hiv infection (9) 9
hiv infections - immunology (9) 9
hiv-1 - isolation & purification (9) 9
uganda - epidemiology (9) 9
anti-hiv agents - therapeutic use (8) 8
child (8) 8
child, preschool (8) 8
hiv-1 - classification (8) 8
microbiology (8) 8
mutations (8) 8
treatment failure (8) 8
drug resistance, viral (7) 7
drug resistance, viral - genetics (7) 7
drug-resistance (7) 7
hiv-1 (7) 7
mortality (7) 7
research (7) 7
therapy (7) 7
viral load (7) 7
africa south of the sahara - epidemiology (6) 6
antiretroviral treatment (6) 6
cd4 lymphocyte count (6) 6
cohort (6) 6
drug therapy (6) 6
viral load - drug effects (6) 6
women (6) 6
abacavir (5) 5
adults (5) 5
anti-hiv agents - administration & dosage (5) 5
antiretroviral agents (5) 5
article (5) 5
children (5) 5
clinical trials (5) 5
cohort studies (5) 5
dosage and administration (5) 5
follow-up studies (5) 5
immunodeficiency-virus type-1 (5) 5
infections (5) 5
middle aged (5) 5
nevirapine (5) 5
plasma (5) 5
prevalence (5) 5
treatment outcome (5) 5
virological failure (5) 5
virus diseases (5) 5
acquired immune deficiency syndrome--aids (4) 4
analysis (4) 4
antiretroviral therapy, highly active (4) 4
care and treatment (4) 4
cd4 antigen (4) 4
failure (4) 4
genotypes (4) 4
highly active antiretroviral therapy (4) 4
hiv drug resistance (4) 4
hiv-1 - immunology (4) 4
infant (4) 4
medicine (4) 4
pediatrics (4) 4
protease inhibitors (4) 4
research article (4) 4
reverse-transcriptase (4) 4
risk factors (4) 4
rna-directed dna polymerase (4) 4
sub-saharan africa (4) 4
subtype-c (4) 4
transmission (4) 4
variants (4) 4
virus replication (4) 4
zimbabwe - epidemiology (4) 4
adherence (3) 3
adolescents (3) 3
anti-hiv agents - pharmacology (3) 3
anti-retroviral agents - pharmacology (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Infectious Diseases, The, ISSN 1473-3099, 2011, Volume 11, Issue 10, pp. 750 - 759
Summary Background There are few data on the epidemiology of primary HIV-1 drug resistance after the roll-out of antiretroviral treatment (ART) in sub-Saharan... 
Infectious Disease | no | SURVEILLANCE | INFECTIOUS DISEASES | MUTATIONS | PREVALENCE | NEVIRAPINE | RECOMMENDATIONS | Anti-HIV Agents - pharmacology | Prevalence | Prospective Studies | Kenya - epidemiology | HIV Infections - epidemiology | Humans | Middle Aged | Uganda - epidemiology | Male | Anti-HIV Agents - administration & dosage | Adult | Female | HIV Infections - transmission | Zambia - epidemiology | Zimbabwe - epidemiology | Thymidine - genetics | Cross-Sectional Studies | HIV-1 - drug effects | HIV Infections - virology | South Africa - epidemiology | Genotype | Drug Resistance, Viral - genetics | Thymidine - analogs & derivatives | Analysis of Variance | Anti-Retroviral Agents - administration & dosage | Nigeria - epidemiology | Drug Resistance, Viral - drug effects | HIV Infections - drug therapy | Aged | Viral Load - drug effects | Africa South of the Sahara - epidemiology | Population Surveillance | Highly active antiretroviral therapy | Antiviral agents | HIV (Viruses) | Drug therapy | Drug resistance | HIV infection | Laboratories | Thymidine | Multivariate analysis | Epidemiology | Risk factors | Gene sequencing | Mathematical analysis | Antiretroviral agents | Human immunodeficiency virus--HIV | Pol gene | Pretreatment | Public health | Antiretroviral drugs | Calendars | Proteinase inhibitors | Risk analysis | Ribonucleic acid--RNA | Resistance factors | Antiretroviral therapy | CD4 antigen | Rolling resistance | Protease inhibitors | Adults | Mutation
Journal Article
AIDS research and therapy, ISSN 1742-6405, 01/2020, Volume 17, Issue 1, pp. 2 - 9
Resistance to antiretroviral drugs is a major challenge among Human Immunodeficiency Virus (HIV) positive patients receiving antiretroviral therapy (ART).... 
HIV drug resistance | ART drug regimen | HIV-1 subtype
Journal Article
PLoS Pathogens, ISSN 1553-7366, 01/2018, Volume 14, Issue 1, p. e1006754
Journal Article
Journal Article
The Journal of Infectious Diseases, ISSN 0022-1899, 01/2019, Volume 219, Issue 1, pp. 89 - 100
Abstract Objective Immune activation is associated with morbidity and mortality during human immunodeficiency virus (HIV) infection, despite receipt of... 
MORTALITY | INFECTIOUS DISEASES | ASSOCIATIONS | immune activation | Africa | MICROBIOLOGY | IMMUNOLOGY | MACROPHAGE ACTIVATION | sequencing | INDIVIDUALS | microbial translocation | RECOVERY | HIV | children | PLASMA-LEVELS | INFLAMMATION | pediatrics | T-CELL-ACTIVATION | RECONSTITUTION | DISEASE PROGRESSION | Major and Brief Reports
Journal Article
PLoS medicine, ISSN 1549-1676, 12/2018, Volume 15, Issue 12, p. e1002706
Background In sub-Saharan Africa, individuals infected with HIV who are severely immunocompromised have high mortality (about 10%) shortly after starting... 
MORTALITY | BIOMARKERS | SOUTH-AFRICA | MEDICINE, GENERAL & INTERNAL | IMMUNE RECONSTITUTION | EFAVIRENZ | ADULTS | INFECTION | RESTORATION | IMMUNODEFICIENCY | CHILDREN | HIV Infections - diagnostic imaging | Africa - epidemiology | Zimbabwe - epidemiology | Drug Administration Schedule | Follow-Up Studies | Kenya - epidemiology | HIV Infections - epidemiology | Humans | Raltegravir Potassium - administration & dosage | Child, Preschool | Malawi - epidemiology | Uganda - epidemiology | Male | Disease Progression | Anti-HIV Agents - administration & dosage | Young Adult | Anti-Retroviral Agents - administration & dosage | Adolescent | Adult | Female | HIV Infections - drug therapy | Child | Health Services Accessibility - trends | Drug therapy | HIV infection | Raltegravir | Testing | Therapy | RNA-directed DNA polymerase | Viremia | Funding | Clinical trials | Risk | Viruses | Infections | Tenofovir | Randomization | Motivation | Antiretroviral agents | Nucleoside reverse transcriptase inhibitors | Human immunodeficiency virus--HIV | Children | Adolescents | Genotypes | Supervision | University colleges | Integrase | Antiretroviral drugs | Medical research | Mortality | Immune reconstitution | Inflammation | Disease control | Antiretroviral therapy | Morbidity | CD4 antigen | Medicine | Amplification | Non-nucleoside reverse transcriptase inhibitors | Inhibitors | Councils | Abacavir | Nucleosides | Biomarkers | Mutation | HIV | Human immunodeficiency virus
Journal Article
by Fitzgerald, Felicity and Lhomme, Édouard and Harris, Kathryn and Doyle, Ronan and Shaw, Liam and Abongomera, George and Brown, Julia and Brooks, Anthony and Prendergast, Andrew and Thiébaut, A and Chintu, Chifumbe and Mulenga, Veronica and Kabamba, Desiree and Kavindele, Dorothy and Chabala, Chishala and Mwenechanya, Musaku and Kapasa, Monica and Zulu, Caroline and Kalumbi, Mox and Lungu, Joyce and Liusha, Marjory and Zangata, Dorothy and Masuka, Dorica and Chambula, Elias and Chanshi, Shadreck and Chipoya, Terence and Zulu, Semy and Chola, Daniel and Chanda, Betty and Malama, Steven and Chama, Chama and Mulambo, Sylvia and Mwanza, Mpala and Asiimwe, A and Tukei, J Vicent and Korutaro, Violet and Komunyena, Justine and Sebuliba, Isaac and Kisekka, Muzamil and Nansubuga, Carolyn and Mpanga, Justine and Matovu, Moses and Okello, Charles and Kesande, Sharon and Namutebi, Gladys and Tumuheirirwe, E Glorius and Nagawa, Immaculate and Nakimera, Sarah and Onen, Geoffrey and Kabasita, Fatuma and Sunday, Fred and Isabirye, Dick and Kityo, Cissy and Musiime, Victor and Mirembe, Grace and Kaudha, Elizabeth and Drasiku, A and Bainomuhwezi, Bernard and Wavamunno, Priscilla and Odongo, Florence and Lukowe, Constance and Namala, Winnie and Sseremba, Daniel and Balaba, A and Kwaga, A and Kayiwa, Joshua and Odera, Matthew and Oronon, Paul and Bagurukira, Edith and Mwesigwa, Phyllis and Apugulu, A and Mugarura, Lincoln and David Williams, Eram and Odoch, Denis and Nankya, Immaculate and Ndashimyeeva, Emmanuel and Nabulime, Eva and Abach, A and Agings Odong, A and Arach, A and Claren Aciro, A and Omongin, Joseph and Amone, A and Okello, Peter and Aleti, A and Otim, Edward and Kidega, Patrick and Achol, A and Mwape, Innocent and Zulu, Joshua and Chipili, Gabriel and Chibesa, Linda and Sarah Walker, A and Thomason, Margaret and Cook, Adrian and Owen-Powell, Ellen and Ferrier, A and Baptiste, David and Male, Charlotte and Murphy, Brendan
Journal of Infectious Diseases, ISSN 0022-1899, 08/2018
Journal Article